Skip to main content
Top
Published in:

Open Access 01-06-2025 | Diabetes | Research article

Grip strength, metabolic syndrome, and type 2 diabetes mellitus: a prospective study

Authors: JinWon Rho, DooYong Park, Yeon Soo Kim

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2025

Login to get access

Abstract

Objectives

This study examines the impact of absolute grip strength (AGS) and relative grip strength (RGS) on the risk of developing type 2 diabetes mellitus (DM), especially in relation to metabolic syndrome (MetS).

Methods

1,935 participants were adults aged 51 to 81 years with an average observation period of 6.50 years. The diagnosis of DM was based on American Diabetes Association. The JAMA 5030J1 dynamometer was used to measure the grip strength. Multivariable extended Cox regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) for DM incidence.

Results

The DM risk increased with the number of MetS risk factors. High AGS was associated with a reduced DM risk (HR = 0.66, 95% CI = 0.44–0.99), but association disappeared when adjusted for MetS. High RGS was significantly associated with a reduced risk of DM incidence (HR = 0.49, 95% CI = 0.33–0.72), even after adjusting for MetS (HR = 0.63, 95% CI = 0.42–0.94). With the presence of MetS, higher AGS was associated with a greater increase in the DM risk compared to lower AGS, while higher RGS was associated with a less increase in the DM risk compared to lower RGS.

Conclusion

This study demonstrates that RGS is a more reliable predictor of DM risks than AGS. Additionally, MetS significantly increases DM risk, particularly in individuals with obesity and hypertension. The study highlights the importance of assessing muscle quality in DM prevention and suggest that improving muscle quality may help mitigate DM risk.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Grip strength, metabolic syndrome, and type 2 diabetes mellitus: a prospective study
Authors
JinWon Rho
DooYong Park
Yeon Soo Kim
Publication date
01-06-2025
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2025
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-025-01614-8

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more